Lexent Bio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $30M

Lexent Bio General Information

Description

Developer of a novel monitoring platform designed to provide clinically actionable information about cancer diagnosis and treatment. The company's platform is based on low-pass whole-genome sequencing (WGS) and DNA methylation analysis offering clinically actionable information about cancer diagnosis, treatment and monitors response to therapy and is faster than imaging, enabling oncologists and their patients to understand if patients are responding to treatment, sooner and more accurately than currently possible.

Contact Information

Website
www.lexentbio.com
Formerly Known As
Impact Genomics, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1000 Brannan Street
  • San Francisco, CA 94103
  • United States
Primary Industry
Decision/Risk Analysis
Acquirer
Foundation Medicine
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1000 Brannan Street
  • San Francisco, CA 94103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lexent Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Jun-2020 $30M Completed Generating Revenue
3. Early Stage VC (Series A) 20-Mar-2019 Completed Generating Revenue
2. Early Stage VC 01-Nov-2017 $10.2M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Nov-2016 $10.2M $10.2M Completed Generating Revenue
To view Lexent Bio’s complete valuation and funding history, request access »

Lexent Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1
Series A
To view Lexent Bio’s complete cap table history, request access »

Lexent Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel monitoring platform designed to provide clinically actionable information about cancer diagnosis an
Decision/Risk Analysis
San Francisco, CA

Vancouver, Canada
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lexent Bio Competitors (2)

One of Lexent Bio’s 2 competitors is Boreal Genomics, a Formerly VC-backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boreal Genomics Formerly VC-backed Vancouver, Canada
Freenome Formerly VC-backed Brisbane, CA
You’re viewing 2 of 2 competitors. Get the full list »

Lexent Bio Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Lexent Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020414737-A1 Methods and systems for molecular disease assessment via analysis of circulating tumor dna Inactive 24-Dec-2019
CA-3165763-A1 Methods and systems for molecular disease assessment via analysis of circulating tumor dna Pending 24-Dec-2019
EP-4081665-A2 Methods and systems for molecular disease assessment via analysis of circulating tumor dna Pending 24-Dec-2019
EP-4081665-A4 Methods and systems for molecular disease assessment via analysis of circulating tumor dna Pending 24-Dec-2019
JP-2026049725-A Methods and systems for molecular disease assessment via analysis of circulating tumor dna Pending 24-Dec-2019 C12Q1/6886
To view Lexent Bio’s complete patent history, request access »

Lexent Bio Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Catalent PE-Backed Company Minority
Charge Ventures Venture Capital Minority
Correlation Ventures Venture Capital Minority
Goodman Capital Venture Capital Minority
Senti Biosciences Holdings Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Lexent Bio FAQs

  • When was Lexent Bio founded?

    Lexent Bio was founded in 2015.

  • Where is Lexent Bio headquartered?

    Lexent Bio is headquartered in San Francisco, CA.

  • What industry is Lexent Bio in?

    Lexent Bio’s primary industry is Decision/Risk Analysis.

  • Is Lexent Bio a private or public company?

    Lexent Bio is a Private company.

  • What is the current valuation of Lexent Bio?

    The current valuation of Lexent Bio is .

  • What is Lexent Bio’s current revenue?

    The current revenue for Lexent Bio is .

  • How much funding has Lexent Bio raised over time?

    Lexent Bio has raised $10.2M.

  • Who are Lexent Bio’s investors?

    Catalent, Charge Ventures, Correlation Ventures, Goodman Capital, and Senti Biosciences Holdings are 5 of 7 investors who have invested in Lexent Bio.

  • Who are Lexent Bio’s competitors?

    Boreal Genomics and Freenome are competitors of Lexent Bio.

  • When was Lexent Bio acquired?

    Lexent Bio was acquired on 12-Jun-2020.

  • Who acquired Lexent Bio?

    Lexent Bio was acquired by Foundation Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process